Company: HRTX
Filing Date: 2025-02-27
Form Type: 10-K
Source: 0000950170-25-028374
Chunk: 138

Company: HERON THERAPEUTICS, INC. /DE/
Filing Date: 2025-02-27
Form: 10-K
Item: Item 1B
Chunk 138
---
,000, 7,000,000, 2,000,000, 2,900,000, 8,490,000 and 7,500,000 shares of common stock, respectively, resulting in an aggregate of 46,690,000 shares of common stock authorized for issuance as of December 31, 2024. At December 31, 2024, there were 12,125,013 shares available for future grant under the 2007 Plan. Any shares that are subject to awards granted pursuant to the 2007 Plan that expire, are cancelled or are forfeited are available for future grant under the 2007 Plan.In 2024, we granted options and RSUs to certain employees outside of the 2007 Plan as inducement equity awards.  All such options to purchase our common stock were granted with an exercise price that equals fair market value of the underlying common stock on the grant dates and expire no later than 10 years from the date of grant. The options are exercisable in accordance with vesting schedules that generally provide for them to be fully vested and exercisable four years after the date of grant. All such RSUs vest ratably over four years. All stock options and RSU granted as inducement equity awards were approved by our Board of Directors and have been registered on Form S-8 with the SEC.The following table summarizes the stock option activity for the year ended December 31, 2024: 

        Outstanding Options

        Weighted-

        Average

        Number of

        Exercise

        Shares

        Price

        Balance at December 31, 2023

        24,575

        $
        7.06

        Granted

        8,158

        $
        2.20

        Exercised

        (485
        )
         
        $
        2.47

        Cancelled

        (6,166
        )
         
        $
        12.02

        Balance at December 31, 2024

        26,082

        $
        4.46

93

The following table summarizes the RSU activity for the year ended December 31, 2024: 

        Outstanding RSUs

        Weighted-

        Average

        Number of

        Grant Date

        Shares

        Fair Value

        Balance at December 31, 2023

        1,405

        $
        4.